WILEX develops diagnostic and therapeutic products for the treatment of renal cell carcinoma... Read more
WILEX develops diagnostic and therapeutic products for the treatment of renal cell carcinoma... Read more
News
Oct 11, 2017
BioSpace
WILEX: Wilex AG: Interim Management Statement For The First Nine Months Of 2017
Oct 10, 2017
BioSpace
WILEX: Wilex AG Announces Adjustment Of Guidance
Sep 26, 2017
BioSpace
WILEX: Wilex AG: Subsidiary Heidelberg Pharma Becomes Runner Up In The Category Best New Drug Developer At World ADC Award 2017
Sep 19, 2017
BioSpace
WILEX: Wilex AG: Subsidiary Heidelberg Pharma To Present The Proprietary ATAC Technology Platform At
Sep 07, 2017
BioPortfolio
WILEX: Wilex AG WL6 Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23082017 Prices from USD $250
Jul 13, 2017
BioSpace
WILEX: Wilex AG Reports First Half 2017 Results
Jun 19, 2017
BioSpace
WILEX: Wilex AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-Target Research Agreement With Takeda For The Development Of Antibody Targeted Amanitin Conjugates
Apr 24, 2017
4-traders
WILEX: DGAP-Adhoc: WILEX AG plans rights issue using authorised capital
Apr 17, 2017
BioPortfolio
WILEX: Wilex AG WL6 Pharmaceuticals Healthcare Deals and Alliances Profile Updated 22032017 Prices from USD $250
Apr 11, 2017
4-traders
WILEX: DGAP-News: WILEX AG: Interim management statement on the first three months of 2017
